Gregory Veillette, MD
Transplant Surgery · Valhalla, NYNPI 1508083817
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (49.9%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. Dilon Technologies, Inc. accounts for 60.9% of it on its own, with 14 other manufacturers making up the rest. 2025 is the largest year on record at $15,978, more than ten times the $159 reported in 2019.
Across 86 payments — averaging $268.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Dilon Technologies, Inc.$14K
- Medtronic$6K
- AbbVie$932
- Davol Inc.$480
- Transmedics, Inc.$439
- W. L. Gore & Associates, Inc.$294
- plus $665 from 9 others
What the payments were for
- Consulting fees$11,50050%
- Speaking & faculty fees$4,50020%
- Travel & lodging$7823%
- Food & beverage$6,14827%
- Education$1311%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Dilon Technologies, Inc. | 31 | $14,055 |
| Medtronic | 24 | $6,196 |
| AbbVie(2 entities) | 9 | $932 |
| Davol Inc. | 6 | $480 |
| Transmedics, Inc. | 1 | $439 |
| W. L. Gore & Associates, Inc. | 4 | $294 |
| Intuitive Surgical | 3 | $165 |
| Kerecis Limited | 1 | $137 |
| Polynovo North America LLC | 1 | $134 |
| Conmed Corporation | 1 | $83 |
| AstraZeneca | 1 | $68 |
| Merck | 1 | $26 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $23 |
| Olympus America Inc. | 1 | $15 |
| Integra Lifesciences Corporation | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HemoBlast Bellows$13,518
- Signia$2,154
- STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS$604
- Kerecis SurgiClose$546
- ORGAN CARE SYSTEM$439
- Phasix Mesh$265
- ENDO GIA ULTRA$234
- LigaSure$167
- Kerecis GraftGuide$137
- Novosorb BTM$134
How this compares
$23,061 in reported general payments places this provider in the 85th percentile of 72 transplant surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other transplant surgery in Valhalla
- Devon JohnValhalla$1K
- Thomas DifloValhalla$1K
- Roberto Hernandez AlejandroRochester$524K
- Tejinder SinghAlbany$513K
- Kishore IyerNew York$95K
- Jason HawksworthNew York$91K
- Parissa TabrizianNew York$74K
- Koji TomiyamaRochester$36K
- Lloyd RatnerNew York$32K
- Hautien LiouNew York$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.